A Study With LJPC-401 for the Treatment of Myocardial Iron Overload in Patients With Transfusion-Dependent Beta Thalassemia
Clinical trial NCT03381833 · TERMINATED
Trial details
- NCT number
- NCT03381833
- Sponsor
- La Jolla Pharmaceutical Company
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-30
- Primary completion
- 2019-12-03
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.